New York · Gabapentin use and a claim for memory loss
Gabapentin use and a claim for memory loss in New York
See If You Qualify
Free · No obligation · About 2 minutes
| Filing deadline | 3 years from discovery of injury; medical monitoring available pre-diagnosisCPLR § 214 |
|---|
Deadlines vary with the facts of each case. A lawyer can confirm yours.
Updated
01 · Your filing deadline
What is the deadline in New York?
New York: 3 years for personal injury (CPLR § 214). Discovery rule applies — limitations begin when the plaintiff discovers or should have discovered the injury and its cause. New York recognizes medical monitoring claims for at-risk populations. A lawyer can confirm yours.
Source: CPLR § 214
Deadlines vary; a lawyer can confirm yours. An older diagnosis or a past filing window does not, by itself, establish whether you have a claim.
02 · Where cases are heard
Where would my case be heard?
New York is a critical jurisdiction for gabapentin litigation due to Pfizer's corporate headquarters at 66 Hudson Boulevard in Manhattan, establishing unambiguous personal jurisdiction over the original manufacturer of Neurontin. The Southern District of New York has managed numerous pharmaceutical MDLs and is experienced in complex mass tort proceedings. New York's massive population of 19.5 million generates the third-highest total gabapentin prescribing volume nationally, with concentrated usage in upstate cities like Buffalo, Syracuse, and Rochester where the opioid crisis hit hard and chronic pain from industrial work is prevalent. The state's world-class medical institutions — including Memorial Sloan Kettering, NYU Langone, Columbia, and Mount Sinai — provide comprehensive neuropsychological evaluation resources.
Pfizer is headquartered at 66 Hudson Boulevard, Manhattan, within the Southern District of New York, providing strong personal jurisdiction. SDNY has extensive pharmaceutical MDL experience. New York state courts offer coordination through mass tort management programs. New York does not cap compensatory damages in product liability cases. The state's recognition of medical monitoring claims allows gabapentin users who have not yet developed dementia to seek ongoing cognitive screening costs. New York follows pure comparative fault.
How this works nationally
For the overall process and updates, read the Gabapentin use and a claim for memory loss overview. This page covers the local information available for New York.
What happens when I check?
You answer a few short questions about what happened. If you send them, your answers are kept on file. If a participating law firm takes these cases, it may contact you. People's Justice is not a law firm.
Live in New York? Read what applies in your state.
Register your interest. If a participating law firm takes these cases, it may contact you.
Register your interestSources
- CPLR § 214